New patent for Azurity drug XATMEPBy DrugPatentWatch – Make Better Decisions / May 24, 2024 Annual Drug Patent Expirations for XATMEP Xatmep is a drug marketed by Azurity and is included in one NDA. It is available from one supplier. There are five patents protecting…Source